Wide Ranks

CHRO

Channel Therapeutics Corporatio

0.6253

Top Statistics
Market Cap 3 M Forward PE -0.5685 Revenue Growth 0.00 %
Current Ratio 0.93 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 2 M Total Cash Per Share 0.4170 Total Debt 1 M
Total Debt To Equity Current Ratio 0.93 Book Value Per Share -1.65
All Measures
Short Ratio 26.00 % Message Board Id finmb_1803540075 Shares Short Prior Month 31672
City Freehold Uuid 6f1c1782-f7b5-3f67-a9fa-2d3ca7aa4092 Previous Close 0.5982
First Trade Date Epoch Utc 1 B Book Value -1.65 Total Debt 1 M
Volume 39860 Fifty Two Week Low 0.4500 Total Cash Per Share 0.4170
Shares Short Previous Month Date 1 B Target Median Price 8.50 Max Age 86400
Sand P52 Week Change 0.3133 Target Mean Price 8.50 Net Income To Common -9794834
Ask 0.6494 Short Percent Of Float 0.0133 Implied Shares Outstanding 6 M
Last Fiscal Year End 1 B Trailing Peg Ratio None Average Daily Volume10 Day 38100
Average Volume10days 38100 Total Cash 2 M Next Fiscal Year End 1 B
Held Percent Insiders 0.8076 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 0.5982 Target Low Price 8.50
Gmt Off Set Milliseconds -18000000 Fifty Day Average 0.6795 Open 0.6024
Free Cashflow -6493229 State NJ Dividend Yield 0.00 %
Return On Assets -4.13 Time Zone Short Name EST Trailing Eps -1.81
Day Low 0.6000 Address1 4400 Route 9 South Shares Outstanding 6 M
Price Hint 4 Target High Price 8.50 Website https://www.chromocell.com
52 Week Change -0.8698 Average Volume 133348 Forward Eps -1.10
Recommendation Key none Compensation As Of Epoch Date 1 B Quick Ratio 86.30 %
Is_sp_500 False Regular Market Day High 0.6500 Profit Margins 0.00 %
Fifty Two Week High 6.00 Day High 0.6500 Shares Short 58233
Regular Market Open 0.6024 Industry Key biotechnology Bid 0.6013
Earnings Growth 0.00 % Revenue Growth 0.00 % Shares Percent Shares Out 0.0101
Operating Cashflow -5558350 Currency USD Time Zone Full Name America/New_York
Market Cap 3 M Is_nasdaq_100 False Zip 07728
Quote Type EQUITY Industry Biotechnology Long Name Channel Therapeutics Corporation
Regular Market Day Low 0.6000 Held Percent Institutions 0.0707 Current Price 0.6253
Address2 Suite 1000 Financial Currency USD Current Ratio 0.93
Industry Disp Biotechnology Number Of Analyst Opinions 1 Country United States
Float Shares 1 M Two Hundred Day Average 1.50 Enterprise Value 2 M
Forward PE -0.5685 Regular Market Volume 39860 Exchange ASE
Go to Yahoo Finance Go to Seeking Alpha 
Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the development and commercialization of new therapeutics to alleviate pain.

The company intends to selectively target the sodium ion-channel known as NaV1.

7, as well as other receptors in the NaV family.

Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain and acute and chronic eye pain.

Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey.